{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:06:26Z","timestamp":1770228386913,"version":"3.49.0"},"reference-count":167,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Anaphylaxis should be clinically diagnosed with immediate recognition, whereas, despite advances\nin the field of allergy, the symptoms of anaphylaxis remain to be under-recognized, diagnosis is often missed,\nand treatment is often delayed. Anaphylaxis presents with symptoms in a spectrum of severity, ranging from\nmild objective breathing problems to circulatory shock and\/or collapse. Indeed, anaphylaxis management frequently\nrelies on a \u2018one-size-fits-all approach\u2019 rather than a precision medicine care model, despite the evidence\nthat anaphylaxis is a heterogeneous condition with differences in causative agents, clinical presentation,\nand host susceptibility. The key important risk factors for severe anaphylaxis and mortality are certain age\ngroups or certain stages of life (infants, elderly and pregnant women), augmenting factors (physical exercise, alcohol\nconsumption, menstruation, acute infections), concurrent use of some medications (beta-adrenergic blockers\n(\u03b2-blockers) and angiotensin-converting enzyme (ACE) inhibitors, non-steroidal anti-inflammatory drugs\n(NSAIDs), and proton pump inhibitors (PPIs), and concomitant diseases (i.e. asthma, cardiovascular disease,\nmastocytosis). The present review aims to collectively address the patient groups who are at high risk of having\nanaphylaxis, those who have a more severe course, those that are difficult to diagnose, and require a special approach\nin treatment. Therefore, the risky populations like the elderly, pregnant women, patients receiving \u03b2-\nblockers or ACE inhibitors, those with concomitant cardiovascular diseases, asthma, and mastocytosis, or those\nhaving higher baseline serum tryptase levels are discussed, including their clinical presentations and treatment\nstrategies. Additionally, anaphylaxis during the perioperative period is addressed.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666221207105214","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T05:34:21Z","timestamp":1670823261000},"page":"224-238","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anaphylaxis in Risky Populations"],"prefix":"10.2174","volume":"29","author":[{"given":"Asl\u0131","family":"Gelincik","sequence":"first","affiliation":[{"name":"Division of Immunology and Allergic\nDiseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1505-4293","authenticated-orcid":true,"given":"\u015eeng\u00fcl","family":"Beyaz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergic Diseases, Ankara City Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","volume":"13","author":"Cardona V.","year":"2020","unstructured":"Cardona V.; Ansotegui I.J.; Ebisawa M.; El-Gamal Y.; Fernandez Rivas M.; Fineman S.; Geller M.; Gonzalez-Estrada A.; Greenberger P.A.; Sanchez Borges M.; Senna G.; Sheikh A.; Tanno L.K.; Thong B.Y.; Turner P.J.; Worm M.; World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020,13(10),100472","journal-title":"World Allergy Organ J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","volume":"145","author":"Shaker M.S.","year":"2020","unstructured":"Shaker M.S.; Wallace D.V.; Golden D.B.K.; Oppenheimer J.; Bernstein J.A.; Campbell R.L.; Dinakar C.; Ellis A.; Greenhawt M.; Khan D.A.; Lang D.M.; Lang E.S.; Lieberman J.A.; Portnoy J.; Rank M.A.; Stukus D.R.; Wang J.; Riblet N.; Bobrownicki A.M.P.; Bontrager T.; Dusin J.; Foley J.; Frederick B.; Fregene E.; Hellerstedt S.; Hassan F.; Hess K.; Horner C.; Huntington K.; Kasireddy P.; Keeler D.; Kim B.; Lieberman P.; Lindhorst E.; McEnany F.; Milbank J.; Murphy H.; Pando O.; Patel A.K.; Ratliff N.; Rhodes R.; Robertson K.; Scott H.; Snell A.; Sullivan R.; Trivedi V.; Wickham A.; Shaker M.S.; Wallace D.V.; Shaker M.S.; Wallace D.V.; Bernstein J.A.; Campbell R.L.; Dinakar C.; Ellis A.; Golden D.B.K.; Greenhawt M.; Lieberman J.A.; Rank M.A.; Stukus D.R.; Wang J.; Shaker M.S.; Wallace D.V.; Golden D.B.K.; Bernstein J.A.; Dinakar C.; Ellis A.; Greenhawt M.; Horner C.; Khan D.A.; Lieberman J.A.; Oppenheimer J.; Rank M.A.; Shaker M.S.; Stukus D.R.; Wang J.; Anaphylaxis-a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol 2020,145(4),1082-1123","journal-title":"J Allergy Clin Immunol"},{"key":"ref=3","author":"Muraro A.","year":"2021","unstructured":"Muraro A.; Worm M.; Alviani C.; EAACI guideline: Anaphylaxis (2021 update). Allergy 2021","journal-title":"Allergy"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11882-021-01006-x","volume":"21","author":"Mikhail I.","year":"2021","unstructured":"Mikhail I.; Stukus D.R.; Prince B.T.; Fatal anaphylaxis: Epidemiology and risk factors. Curr Allergy Asthma Rep 2021,21(4),28","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jaci.2013.06.015","volume":"132","author":"Brown S.G.A.","year":"2013","unstructured":"Brown S.G.A.; Stone S.F.; Fatovich D.M.; Burrows S.A.; Holdgate A.; Celenza A.; Coulson A.; Hartnett L.; Nagree Y.; Cotterell C.; Isbister G.K.; Anaphylaxis: Clinical patterns, mediator release, and severity. J Allergy Clin Immunol 2013,132(5),1141-1149.e5","journal-title":"J Allergy Clin Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/JAA.S159411","volume":"11","author":"Jimenez-Rodriguez T.","year":"2018","unstructured":"Jimenez-Rodriguez T.; Garcia-Neuer M.; Alenazy L.A.; Castells M.; Anaphylaxis in the 21st century: Phenotypes, endotypes, and biomarkers. J Asthma Allergy 2018,11,121-142","journal-title":"J Asthma Allergy"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","volume":"140","author":"Castells M.","year":"2017","unstructured":"Castells M.; Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol 2017,140(2),321-333","journal-title":"J Allergy Clin Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.23822\/EurAnnACI.1764-1489.158","volume":"53","author":"Bil&#xF2; M.B.","year":"2020","unstructured":"Bil&#xF2; M.B.; Martini M.; Tontini C.; Corsi A.; Antonicelli L.; Anaphylaxis. Eur Ann Allergy Clin Immunol 2020,53(1),4-17","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.resuscitation.2021.04.010","volume":"163","author":"Dodd A.","year":"2021","unstructured":"Dodd A.; Hughes A.; Sargant N.; Whyte A.F.; Soar J.; Turner P.J.; Evidence update for the treatment of anaphylaxis. Resuscitation 2021,163,86-96","journal-title":"Resuscitation"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3389\/fimmu.2017.01193","volume":"8","author":"Mu&#xF1;oz-Cano R.","year":"2017","unstructured":"Mu&#xF1;oz-Cano R.; Pascal M.; Araujo G.; Goikoetxea M.J.; Valero A.L.; Picado C.; Bartra J.; Mechanisms, cofactors, and augmenting factors involved in anaphylaxis. Front Immunol 2017,8,1193","journal-title":"Front Immunol"},{"key":"ref=11","first-page":"3","volume":"13","author":"El-Gamal Y.","year":"2015","unstructured":"El-Gamal Y.; Anaphylaxis vulnerable groups. Egypt J Pediatr Allergy Immunol 2015,13(1),3-6","journal-title":"Egypt J Pediatr Allergy Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000507445","volume":"181","author":"Regateiro F.S.","year":"2020","unstructured":"Regateiro F.S.; Marques M.L.; Gomes E.R.; Drug-induced anaphylaxis: An update on epidemiology and risk factors. Int Arch Allergy Immunol 2020,181(7),481-487","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.anai.2017.07.014","volume":"119","author":"Motosue M.S.","year":"2017","unstructured":"Motosue M.S.; Bellolio M.F.; Van Houten H.K.; Shah N.D.; Campbell R.L.; Risk factors for severe anaphylaxis in the United States. Ann Allergy Asthma Immunol 2017,119(4),356-361.e2","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/all.13380","volume":"73","author":"Worm M.","year":"2018","unstructured":"Worm M.; Francuzik W.; Renaudin J.M.; Bilo M.B.; Cardona V.; Scherer Hofmeier K.; K&#xF6;hli A.; Bauer A.; Christoff G.; Cichocka-Jarosz E.; Hawranek T.; Hourihane J.O.B.; Lange L.; Mahler V.; Muraro A.; Papadopoulos N.G.; Pf&#xF6;hler C.; Poziomkowska-G\u0119sicka I.; Ru&#xEB;ff F.; Spindler T.; Treudler R.; Fernandez-Rivas M.; D&#xF6;lle S.; Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European anaphylaxis registry. Allergy 2018,73(6),1322-1330","journal-title":"Allergy"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","volume":"5","author":"Turner P.J.","year":"2017","unstructured":"Turner P.J.; Jerschow E.; Umasunthar T.; Lin R.; Campbell D.E.; Boyle R.J.; Fatal anaphylaxis: Mortality rate and risk factors. J Allergy Clin Immunol Pract 2017,5(5),1169-1178","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=16","author":"Dribin T.E.","year":"2021","unstructured":"Dribin T.E.; Schnadower D.; Wang J.; Anaphylaxis knowledge gaps and future research priorities: A consensus report. J Allergy Clin Immunol 2021","journal-title":"J Allergy Clin Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","volume":"133","author":"Wood R.A.","year":"2014","unstructured":"Wood R.A.; Camargo C.A.; Lieberman P.; Sampson H.A.; Schwartz L.B.; Zitt M.; Collins C.; Tringale M.; Wilkinson M.; Boyle J.; Simons F.E.R.; Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol 2014,133(2),461-467","journal-title":"J Allergy Clin Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","volume":"135","author":"Turner P.J.","year":"2015","unstructured":"Turner P.J.; Gowland M.H.; Sharma V.; Ierodiakonou D.; Harper N.; Garcez T.; Pumphrey R.; Boyle R.J.; Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 2015,135(4),956-963.e1","journal-title":"J Allergy Clin Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/life11090870","volume":"11","author":"Simionescu A.A.","year":"2021","unstructured":"Simionescu A.A.; Stanescu A.M.A.; Popescu F.D.; State-of-the-art on biomarkers for anaphylaxis in obstetrics. Life 2021,11(9),870","journal-title":"Life"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/all.14468","volume":"75","author":"Tanno L.K.","year":"2020","unstructured":"Tanno L.K.; Chalmers R.; Jacob R.; Kostanjsek N.; Bierrenbach A.L.; Martin B.; Molinari N.; Annesi-Maesano I.; Papadopoulos N.G.; Sanchez-Borges M.; Rosenwasser L.J.; Ansontegui I.; Ebisawa M.; Sisul J.C.; Jares E.; Gomez M.; Agache I.; Muraro A.; Wong G.W.K.; Thien F.; Pawankar R.; Mahr T.A.; Sublett J.L.; Lang D.M.; Casale T.; Demoly P.; Global implementation of the world health organization\u2019s International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model. Allergy 2020,75(9),2206-2218","journal-title":"Allergy"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fimmu.2019.00750","volume":"10","author":"Aurich S.","year":"2019","unstructured":"Aurich S.; D&#xF6;lle-Bierke S.; Francuzik W.; Bilo M.B.; Christoff G.; Fernandez-Rivas M.; Hawranek T.; Pf&#xF6;hler C.; Poziomkowska-G\u0229sicka I.; Renaudin J.M.; Oppel E.; Scherer K.; Treudler R.; Worm M.; Anaphylaxis in elderly patients-data from the european anaphylaxis registry. Front Immunol 2019,10,750","journal-title":"Front Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-7022-1-11","volume":"1","author":"Cardona V.","year":"2011","unstructured":"Cardona V.; Guilarte M.; Luengo O.; Labrador-Horrillo M.; Sala-Cunill A.; Garriga T.; Allergic diseases in the elderly. Clin Transl Allergy 2011,1(1),11","journal-title":"Clin Transl Allergy"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ACI.0000000000000280","volume":"16","author":"Gonz&#xE1;lez-de-Olano D.","year":"2016","unstructured":"Gonz&#xE1;lez-de-Olano D.; Lombardo C.; Gonz&#xE1;lez-Mancebo E.; The difficult management of anaphylaxis in the elderly. Curr Opin Allergy Clin Immunol 2016,16(4),352-360","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1586\/1744666X.2015.1081564","volume":"11","author":"Ventura M.T.","year":"2015","unstructured":"Ventura M.T.; Scichilone N.; Gelardi M.; Patella V.; Ridolo E.; Management of allergic disease in the elderly: Key considerations, recommendations and emerging therapies. Expert Rev Clin Immunol 2015,11(11),1219-1228","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.anai.2011.01.011","volume":"106","author":"Campbell R.L.","year":"2011","unstructured":"Campbell R.L.; Hagan J.B.; Li J.T.C.; Vukov S.C.; Kanthala A.R.; Smith V.D.; Manivannan V.; Bellolio M.F.; Decker W.W.; Anaphylaxis in emergency department patients 50 or 65 years or older. Ann Allergy Asthma Immunol 2011,106(5),401-406","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jaci.2014.05.018","volume":"134","author":"Clark S.","year":"2014","unstructured":"Clark S.; Wei W.; Rudders S.A.; Camargo C.A.; Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol 2014,134(5),1125-1130","journal-title":"J Allergy Clin Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/all.14352","volume":"75","author":"Bil&#xF2; M.B.","year":"2020","unstructured":"Bil&#xF2; M.B.; Corsi A.; Martini M.; Penza E.; Grippo F.; Bignardi D.; Fatal anaphylaxis in Italy: Analysis of cause-of-death national data, 2004-2016. Allergy 2020,75(10),2644-2652","journal-title":"Allergy"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/cea.12520","volume":"45","author":"Lieberman P.","year":"2015","unstructured":"Lieberman P.; Simons F.E.R.; Anaphylaxis and cardiovascular disease: Therapeutic dilemmas. Clin Exp Allergy 2015,45(8),1288-1295","journal-title":"Clin Exp Allergy"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","volume":"133","author":"Ma L.","year":"2014","unstructured":"Ma L.; Danoff T.M.; Borish L.; Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014,133(4),1075-1083","journal-title":"J Allergy Clin Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12948-017-0059-2","volume":"15","author":"Ventura M.T.","year":"2017","unstructured":"Ventura M.T.; Scichilone N.; Paganelli R.; Minciullo P.L.; Patella V.; Bonini M.; Passalacqua G.; Lombardi C.; Simioni L.; Ridolo E.; Del Giacco S.R.; Gangemi S.; Canonica G.W.; Allergic diseases in the elderly: Biological characteristics and main immunological and non-immunological mechanisms. Clin Mol Allergy 2017,15(1),2","journal-title":"Clin Mol Allergy"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","volume":"4","author":"Simons F.E.R.","year":"2011","unstructured":"Simons F.E.R.; Ardusso L.R.F.; Bil&#xF2; M.B.; El-Gamal Y.M.; Ledford D.K.; Ring J.; Sanchez-Borges M.; Senna G.E.; Sheikh A.; Thong B.Y.; World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011,4(2),13-37","journal-title":"World Allergy Organ J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/1745509X.4.4.377","volume":"4","author":"Khan B.Q.","year":"2008","unstructured":"Khan B.Q.; Lieberman P.; Anaphylaxis in the elderly. Aging Health 2008,4(4),377-387","journal-title":"Aging Health"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1111\/all.14838","volume":"76","author":"Bousquet J.","year":"2021","unstructured":"Bousquet J.; Agache I.; Blain H.; Jutel M.; Ventura M.T.; Worm M.; Del Giacco S.; Benetos A.; Bilo B.M.; Czarlewski W.; Abdul Latiff A.H.; Al-Ahmad M.; Angier E.; Annesi-Maesano I.; Atanaskovic-Markovic M.; Bachert C.; Barbaud A.; Bedbrook A.; Bennoor K.S.; Berghea E.C.; Bindslev-Jensen C.; Bonini S.; Bosnic-Anticevich S.; Brockow K.; Brussino L.; Camargos P.; Canonica G.W.; Cardona V.; Carreiro-Martins P.; Carriazo A.; Casale T.; Caubet J.C.; Cecchi L.; Cherubini A.; Christoff G.; Chu D.K.; Cruz A.A.; Dokic D.; El-Gamal Y.; Ebisawa M.; Eberlein B.; Farrell J.; Fernandez-Rivas M.; Fokkens W.J.; Fonseca J.A.; Gao Y.; Gavazzi G.; Gawlik R.; Gelincik A.; Gemicio&#x11F;lu B.; Gotua M.; Gu&#xE9;rin O.; Haahtela T.; Hoffmann-Sommergruber K.; Hoffmann H.J.; Hofmann M.; Hrubisko M.; Illario M.; Irani C.; Ispayeva Z.; Ivancevich J.C.; Julge K.; Kaidashev I.; Khaitov M.; Knol E.; Kraxner H.; Kuna P.; Kvedariene V.; Lauerma A.; Le L.T.T.; Le Moing V.; Levin M.; Louis R.; Lourenco O.; Mahler V.; Martin F.C.; Matucci A.; Milenkovic B.; Miot S.; Montella E.; Morais-Almeida M.; Mortz C.G.; Mullol J.; Namazova-Baranova L.; Neffen H.; Nekam K.; Niedoszytko M.; Odemyr M.; O\u2019Hehir R.E.; Okamoto Y.; Ollert M.; Palomares O.; Papadopoulos N.G.; Panzner P.; Passalacqua G.; Patella V.; Petrovic M.; Pfaar O.; Pham-Thi N.; Plavec D.; Popov T.A.; Recto M.T.; Regateiro F.S.; Reynes J.; Roller-Winsberger R.E.; Rolland Y.; Romano A.; Rondon C.; Rottem M.; Rouadi P.W.; Salles N.; Samolinski B.; Santos A.F.; S Sarquis F.; Sastre J.; M G A Schols J.; Scichilone N.; Sediva A.; Shamji M.H.; Sheikh A.; Skypala I.; Smolinska S.; Sokolowska M.; Sousa-Pinto B.; Sova M.; Stelmach R.; Sturm G.; Suppli Ulrik C.; Todo-Bom A.M.; Toppila-Salmi S.; Tsiligianni I.; Torres M.; Untersmayr E.; Urrutia Pereira M.; Valiulis A.; Vitte J.; Vultaggio A.; Wallace D.; Walusiak-Skorupa J.; Wang D.Y.; Waserman S.; Yorgancioglu A.; Yusuf O.M.; Zernotti M.; Zidarn M.; Chivato T.; Akdis C.A.; Zuberbier T.; Klimek L.; Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy 2021,76(10),2952-2964","journal-title":"Allergy"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1213\/01.ANE.0000050768.04953.16","volume":"96","author":"Hepner D.L.","year":"2003","unstructured":"Hepner D.L.; Castells M.C.; Latex allergy: An update. Anesth Analg 2003,96(4),1219-1229","journal-title":"Anesth Analg"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11882-005-0051-7","volume":"5","author":"Cochran S.T.","year":"2005","unstructured":"Cochran S.T.; Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep 2005,5(1),28-31","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1398-9995.2006.00982.x","volume":"61","author":"Ebo D.G.","year":"2006","unstructured":"Ebo D.G.; Bosmans J.L.; Couttenye M.M.; Stevens W.J.; Haemodialysis-associated anaphylactic and anaphylactoid reactions. Allergy 2006,61(2),211-220","journal-title":"Allergy"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.anai.2020.06.008","volume":"125","author":"Patel C.","year":"2020","unstructured":"Patel C.; Haque M.; Waqar O.; Kline M.; Jongco A.; New York State cases of anaphylaxis in elderly patients from 2000 to 2010. Ann Allergy Asthma Immunol 2020,125(4),410-417.e2","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/ACI.0000000000000071","volume":"14","author":"Triggiani M.","year":"2014","unstructured":"Triggiani M.; Montagni M.; Parente R.; Ridolo E.; Anaphylaxis and cardiovascular diseases. Curr Opin Allergy Clin Immunol 2014,14(4),309-315","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2249.2008.03714.x","volume":"153","author":"Triggiani M.","year":"2008","unstructured":"Triggiani M.; Patella V.; Staiano R.I.; Granata F.; Marone G.; Allergy and the cardiovascular system. Clin Exp Immunol 2008,153(Suppl 1),7-11","journal-title":"Clin Exp Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1398-9995.2012.02795.x","volume":"67","author":"Worm M.","year":"2012","unstructured":"Worm M.; Edenharter G.; Ru&#xEB;ff F.; Scherer K.; Pf&#xF6;hler C.; Mahler V.; Treudler R.; Lang R.; Nemat K.; Koehli A.; Niggemann B.; Hompes S.; Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012,67(5),691-698","journal-title":"Allergy"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","volume":"131","author":"Lee S.","year":"2013","unstructured":"Lee S.; Hess E.P.; Nestler D.M.; Bellamkonda Athmaram V.R.; Bellolio M.F.; Decker W.W.; Li J.T.C.; Hagan J.B.; Manivannan V.; Vukov S.C.; Campbell R.L.; Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis. J Allergy Clin Immunol 2013,131(4),1103-1108","journal-title":"J Allergy Clin Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/all.12908","volume":"71","author":"Bil&#xF2; M.B.","year":"2016","unstructured":"Bil&#xF2; M.B.; Cichocka-Jarosz E.; Pumphrey R.; Oude-Elberink J.N.; Lange J.; Jakob T.; Bonadonna P.; Fernandez J.; Kosnik M.; Helbling A.; Mosbech H.; Gawlik R.; Niedoszytko M.; Patella V.; Pravettoni V.; Rodrigues-Alves R.; Sturm G.J.; Rueff F.; Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI task force consensus statement. Allergy 2016,71(7),931-943","journal-title":"Allergy"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12948-018-0083-x","volume":"16","author":"Ventura M.T.","year":"2018","unstructured":"Ventura M.T.; Boni E.; Cecere R.; Buquicchio R.; Calogiuri G.F.; Martignago I.; Incorvaia C.; Ridolo E.; Importance of hypersensitivity in adverse reactions to drugs in the elderly. Clin Mol Allergy 2018,16(1),7","journal-title":"Clin Mol Allergy"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1398-9995.2008.01733.x","volume":"63","author":"Kemp S.F.","year":"2008","unstructured":"Kemp S.F.; Lockey R.F.; Simons F.E.R.; Epinephrine: The drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008,63(8),1061-1070","journal-title":"Allergy"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40629-020-00158-y","volume":"30","author":"Ring J.","year":"2021","unstructured":"Ring J.; Beyer K.; Biedermann T.; Bircher A.; Fischer M.; Fuchs T.; Heller A.; Hoffmann F.; Huttegger I.; Jakob T.; Klimek L.; Kopp M.V.; Kugler C.; Lange L.; Pfaar O.; Rietschel E.; Rueff F.; Schnadt S.; Seifert R.; St&#xF6;cker B.; Treudler R.; Vogelberg C.; Werfel T.; Worm M.; Sitter H.; Brockow K.; Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update. Allergo J Int 2021,30(1),1-25","journal-title":"Allergo J Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s40629-014-0009-1","volume":"23","author":"Ring J.","year":"2014","unstructured":"Ring J.; Beyer K.; Biedermann T.; Bircher A.; Duda D.; Fischer J.; Friedrichs F.; Fuchs T.; Gieler U.; Jakob T.; Klimek L.; Lange L.; Merk H.F.; Niggemann B.; Pfaar O.; Przybilla B.; Ru&#xEB;ff F.; Rietschel E.; Schnadt S.; Seifert R.; Sitter H.; Varga E.M.; Worm M.; Brockow K.; Guideline for acute therapy and management of anaphylaxis. Allergo J Int 2014,23(3),96-112","journal-title":"Allergo J Int"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/all.12437","volume":"69","author":"Muraro A.","year":"2014","unstructured":"Muraro A.; Roberts G.; Worm M.; Bil&#xF2; M.B.; Brockow K.; Fern&#xE1;ndez Rivas M.; Santos A.F.; Zolkipli Z.Q.; Bellou A.; Beyer K.; Bindslev-Jensen C.; Cardona V.; Clark A.T.; Demoly P.; Dubois A.E.J.; DunnGalvin A.; Eigenmann P.; Halken S.; Harada L.; Lack G.; Jutel M.; Niggemann B.; Ru&#xEB;ff F.; Timmermans F.; Vlieg-Boerstra B.J.; Werfel T.; Dhami S.; Panesar S.; Akdis C.A.; Sheikh A.; Anaphylaxis: Guidelines from the European academy of allergy and clinical immunology. Allergy 2014,69(8),1026-1045","journal-title":"Allergy"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/ACI.0b013e32833bc670","volume":"10","author":"Simons K.J.","year":"2010","unstructured":"Simons K.J.; Simons F.E.R.; Epinephrine and its use in anaphylaxis: Current issues. Curr Opin Allergy Clin Immunol 2010,10(4),354-361","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","volume":"3","author":"Campbell R.L.","year":"2015","unstructured":"Campbell R.L.; Bellolio M.F.; Knutson B.D.; Bellamkonda V.R.; Fedko M.G.; Nestler D.M.; Hess E.P.; Epinephrine in anaphylaxis: Higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract 2015,3(1),76-80","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"100066","DOI":"10.1016\/j.waojou.2019.100066","volume":"12","author":"Turner P.J.","year":"2019","unstructured":"Turner P.J.; Worm M.; Ansotegui I.J.; El-Gamal Y.; Rivas M.F.; Fineman S.; Geller M.; Gonzalez-Estrada A.; Greenberger P.A.; Tanno L.K.; S&#xE1;nchez-Borges M.; Senna G.; Sheikh A.; Thong B.Y.; Ebisawa M.; Cardona V.; Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J 2019,12(10),100066","journal-title":"World Allergy Organ J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/anae.15069","volume":"75","author":"McCall S.J.","year":"2020","unstructured":"McCall S.J.; Bonnet M.P.; &#xC4;yr&#xE4;s O.; Vandenberghe G.; Gissler M.; Zhang W.H.; Van Leeuw V.; Deneux-Tharaux C.; Kurinczuk J.J.; Knight M.; Anaphylaxis in pregnancy: A population-based multinational European study. Anaesthesia 2020,75(11),1469-1475","journal-title":"Anaesthesia"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1016\/j.bja.2018.12.009","volume":"123","author":"Tacquard C.","year":"2019","unstructured":"Tacquard C.; Chassard D.; Malinovsky J.M.; Saucedo M.; Deneux-Tharaux C.; Mertes P.M.; Anaphylaxis-related mortality in the obstetrical setting: Analysis of the French National Confidential Enquiry into maternal deaths from 2001 to 2012. Br J Anaesth 2019,123(1),e151-e153","journal-title":"Br J Anaesth"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1016\/j.jaip.2021.07.046","volume":"9","author":"Carra S.","year":"2021","unstructured":"Carra S.; Schatz M.; Mertes P.M.; Torres M.J.; Fuchs F.; Senna G.; Castells M.C.; Demoly P.; Tanno L.K.; Anaphylaxis and pregnancy: A systematic review and call for public health actions. J Allergy Clin Immunol Pract 2021,9(12),4270-4278","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2012.06.035","volume":"130","author":"Simons F.E.R.","year":"2012","unstructured":"Simons F.E.R.; Schatz M.; Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012,130(3),597-606","journal-title":"J Allergy Clin Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/1471-0528.15041","volume":"125","author":"McCall S.J.","year":"2018","unstructured":"McCall S.J.; Bunch K.J.; Brocklehurst P.; D\u2019Arcy R.; Hinshaw K.; Kurinczuk J.J.; Lucas D.N.; Stenson B.; Tuffnell D.J.; Knight M.; The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: A population-based descriptive study. BJOG 2018,125(8),965-971","journal-title":"BJOG"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/j.jaip.2019.04.047","volume":"7","author":"McCall S.J.","year":"2019","unstructured":"McCall S.J.; Kurinczuk J.J.; Knight M.; Anaphylaxis in pregnancy in the United States: Risk factors and temporal trends using national routinely collected data. J Allergy Clin Immunol Pract 2019,7(8),2606-2612.e3","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.anai.2009.11.005","volume":"104","author":"Mulla Z.D.","year":"2010","unstructured":"Mulla Z.D.; Ebrahim M.S.; Gonzalez J.L.; Anaphylaxis in the obstetric patient: Analysis of a statewide hospital discharge database. Ann Allergy Asthma Immunol 2010,104(1),55-59","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1213\/ANE.0b013e3182a706c7","volume":"117","author":"Hepner D.L.","year":"2013","unstructured":"Hepner D.L.; Castells M.; Mouton-Faivre C.; Dewachter P.; Anaphylaxis in the clinical setting of obstetric anesthesia: A literature review. Anesth Analg 2013,117(6),1357-1367","journal-title":"Anesth Analg"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijoa.2008.05.002","volume":"17","author":"Chaudhuri K.","year":"2008","unstructured":"Chaudhuri K.; Gonzales J.; Jesurun C.A.; Ambat M.T.; Mandal-Chaudhuri S.; Anaphylactic shock in pregnancy: A case study and review of the literature. Int J Obstet Anesth 2008,17(4),350-357","journal-title":"Int J Obstet Anesth"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/ALN.0b013e318206ff50","volume":"114","author":"Draisci G.","year":"2011","unstructured":"Draisci G.; Zanfini B.A.; Nucera E.; Catarci S.; Sangregorio R.; Schiavino D.; Mannocci A.; Patriarca G.; Latex sensitization. Anesthesiology 2011,114(3),565-569","journal-title":"Anesthesiology"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1515\/JPM.2004.070","volume":"32","author":"Berardi A.","year":"2004","unstructured":"Berardi A.; Rossi K.; Cavalleri F.; Simoni A.; Aguzzoli L.; Masellis G.; Ferrari F.; Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis. J Perinat Med 2004,32(4),375-377","journal-title":"J Perinat Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3389\/fimmu.2019.02317","volume":"10","author":"Yang F.","year":"2019","unstructured":"Yang F.; Zheng Q.; Jin L.; Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface. Front Immunol 2019,10,2317","journal-title":"Front Immunol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.23822\/EurAnnACI.1764-1489.198","volume":"54","author":"Liccardi G.","year":"2021","unstructured":"Liccardi G.; Milanese M.; Bilo M.B.; Lessons from peculiar cases of anaphylaxis: Why allergists should be prepared for the unexpected. Eur Ann Allergy Clin Immunol 2021,54(3),99-106","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/AOG.0b013e318242d3c5","volume":"119","author":"Watson K.D.","year":"2012","unstructured":"Watson K.D.; Arendt K.W.; Watson W.J.; Volcheck G.W.; Systemic mastocytosis complicating pregnancy. Obstet Gynecol 2012,119(2 Pt 2),486-489","journal-title":"Obstet Gynecol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaip.2017.05.021","volume":"5","author":"Lei D.","year":"2017","unstructured":"Lei D.; Akin C.; Kovalszki A.; Management of mastocytosis in pregnancy: A review. J Allergy Clin Immunol Pract 2017,5(5),1217-1223","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.anai.2013.03.014","volume":"110","author":"Liccardi G.","year":"2013","unstructured":"Liccardi G.; Bil&#xF2; M.B.; Mauro C.; Salzillo A.; Piccolo A.; D\u2019Amato M.; D\u2019Amato G.; Oxytocin: A likely underestimated risk for anaphylactic reactions in delivering women sensitized to latex. Ann Allergy Asthma Immunol 2013,110(6),465-466","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/2049-6958-8-67","volume":"8","author":"Liccardi G.","year":"2013","unstructured":"Liccardi G.; Bil&#xF2; M.B.; Mauro C.; Salzillo A.; Piccolo A.; D\u2019Amato M.; Liccardi A.; D\u2019Amato G.; Oxytocin: An unexpected risk for cardiologic and broncho-obstructive effects, and allergic reactions in susceptible delivering women. Multidiscip Respir Med 2013,8(1),67","journal-title":"Multidiscip Respir Med"},{"key":"ref=68","first-page":"1332","volume":"102","author":"Gei A.F.","year":"2003","unstructured":"Gei A.F.; Pacheco L.D.; Vanhook J.W.; Hankins G.D.; The use of a continuous infusion of epinephrine for anaphylactic shock during labor. Obstet Gynecol 2003,102(6),1332-1335","journal-title":"Obstet Gynecol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jaip.2017.05.009","volume":"5","author":"Carlson G.S.","year":"2017","unstructured":"Carlson G.S.; Wong P.H.; White K.M.; Quinn J.M.; Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions. J Allergy Clin Immunol Pract 2017,5(5),1430-1432","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0091-6749(81)90170-6","volume":"68","author":"Jacobs R.L.","year":"1981","unstructured":"Jacobs R.L.; Rake G.W.; Fournier D.C.; Chilton R.J.; Culver W.G.; Beckmann C.H.; Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. J Allergy Clin Immunol 1981,68(2),125-127","journal-title":"J Allergy Clin Immunol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","volume":"114","author":"Brown S.G.A.","year":"2004","unstructured":"Brown S.G.A.; Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004,114(2),371-376","journal-title":"J Allergy Clin Immunol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","volume":"135","author":"Nassiri M.","year":"2015","unstructured":"Nassiri M.; Babina M.; D&#xF6;lle S.; Edenharter G.; Ru&#xEB;ff F.; Worm M.; Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming. J Allergy Clin Immunol 2015,135(2),491-499","journal-title":"J Allergy Clin Immunol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jaip.2018.10.042","volume":"7","author":"Tejedor-Alonso M.A.","year":"2019","unstructured":"Tejedor-Alonso M.A.; Farias-Aquino E.; P&#xE9;rez-Fern&#xE1;ndez E.; Grifol-Clar E.; Moro-Moro M.; Rosado-Ingelmo A.; Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: A systematic review and meta-analysis of observational studies. J Allergy Clin Immunol Pract 2019,7(3),879-897.e5","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/ACI.0000000000000468","volume":"18","author":"De Feo G.","year":"2018","unstructured":"De Feo G.; Parente R.; Triggiani M.; Pitfalls in anaphylaxis. Curr Opin Allergy Clin Immunol 2018,18(5),382-386","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jaip.2017.04.033","volume":"5","author":"Coop C.A.","year":"2017","unstructured":"Coop C.A.; Schapira R.S.; Freeman T.M.; Are ACE inhibitors and beta-blockers dangerous in patients at risk for anaphylaxis? J Allergy Clin Immunol Pract 2017,5(5),1207-1211","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2500\/aap.2008.29.3141","volume":"29","author":"Rank M.A.","year":"2008","unstructured":"Rank M.A.; Oslie C.L.; Krogman J.L.; Park M.A.; Li J.T.; Allergen immunotherapy safety: Characterizing systemic reactions and identifying risk factors. Allergy Asthma Proc 2008,29(4),400-405","journal-title":"Allergy Asthma Proc"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1081-1206(10)60321-3","volume":"101","author":"White K.M.","year":"2008","unstructured":"White K.M.; England R.W.; Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy. Ann Allergy Asthma Immunol 2008,101(4),426-430","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1111\/all.14785","volume":"76","author":"Sturm G.J.","year":"2021","unstructured":"Sturm G.J.; Herzog S.A.; Aberer W.; Alfaya Arias T.; Antol&#xED;n-Am&#xE9;rigo D.; Bonadonna P.; Boni E.; Bo&#x17C;ek A.; Che\u0142mi\u0144ska M.; Ernst B.; Frelih N.; Gawlik R.; Gelincik A.; Hawranek T.; Hoetzenecker W.; Jim&#xE9;nez Blanco A.; Kita K.; Kendirlinan R.; Ko\u0161nik M.; Laipold K.; Lang R.; Marchi F.; Mauro M.; Nittner-Marszalska M.; Poziomkowska-G\u0119sicka I.; Pravettoni V.; Preziosi D.; Quercia O.; Reider N.; Rosiek-Biegus M.; Ruiz-Leon B.; Schrautzer C.; Serrano P.; Sin A.; Sin B.A.; Stoevesandt J.; Trautmann A.; Vachov&#xE1; M.; Arzt-Gradwohl L.; &#x3B2;-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy. Allergy 2021,76(7),2166-2176","journal-title":"Allergy"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","volume":"130","author":"Stoevesandt J.","year":"2012","unstructured":"Stoevesandt J.; Hain J.; Kerstan A.; Trautmann A.; Over and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: Cardiovascular medication and absence of urticaria\/angioedema. J Allergy Clin Immunol 2012,130(3),698-704.e1","journal-title":"J Allergy Clin Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.jaip.2020.04.002","volume":"8","author":"Greenberger P.A.","year":"2020","unstructured":"Greenberger P.A.; Evidence accumulates against angiotensin-converting enzyme inhibitors and beta-adrenergic blockers as important co-factors for anaphylactic reactions. J Allergy Clin Immunol Pract 2020,8(6),1906-1907","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","volume":"118","author":"Golden D.B.K.","year":"2017","unstructured":"Golden D.B.K.; Demain J.; Freeman T.; Graft D.; Tankersley M.; Tracy J.; Blessing-Moore J.; Bernstein D.; Dinakar C.; Greenhawt M.; Khan D.; Lang D.; Nicklas R.; Oppenheimer J.; Portnoy J.; Randolph C.; Schuller D.; Wallace D.; Stinging insect hypersensitivity. Ann Allergy Asthma Immunol 2017,118(1),28-54","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/all.13262","volume":"73","author":"Sturm G.J.","year":"2018","unstructured":"Sturm G.J.; Varga E.M.; Roberts G.; Mosbech H.; Bil&#xF2; M.B.; Akdis C.A.; Antol&#xED;n-Am&#xE9;rigo D.; Cichocka-Jarosz E.; Gawlik R.; Jakob T.; Kosnik M.; Lange J.; Mingomataj E.; Mitsias D.I.; Ollert M.; Oude Elberink J.N.G.; Pfaar O.; Pitsios C.; Pravettoni V.; Ru&#xEB;ff F.; Sin B.A.; Agache I.; Angier E.; Arasi S.; Calder&#xF3;n M.A.; Fernandez-Rivas M.; Halken S.; Jutel M.; Lau S.; Pajno G.B.; van Ree R.; Ryan D.; Spranger O.; van Wijk R.G.; Dhami S.; Zaman H.; Sheikh A.; Muraro A.; EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy 2018,73(4),744-764","journal-title":"Allergy"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","volume":"126","author":"Ru&#xEB;ff F.","year":"2010","unstructured":"Ru&#xEB;ff F.; Przybilla B.; Bil&#xF3; M.B.; M&#xFC;ller U.; Scheipl F.; Aberer W.; Birnbaum J.; Bodzenta-Lukaszyk A.; Bonifazi F.; Bucher C.; Campi P.; Darsow U.; Egger C.; Haeberli G.; Hawranek T.; Kucharewicz I.; K&#xFC;chenhoff H.; Lang R.; Quercia O.; Reider N.; Severino M.; Sticherling M.; Sturm G.J.; W&#xFC;thrich B.; Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase. J Allergy Clin Immunol 2010,126(1),105-111.e5","journal-title":"J Allergy Clin Immunol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/cea.12276","volume":"44","author":"Stoevesandt J.","year":"2014","unstructured":"Stoevesandt J.; Hain J.; Stolze I.; Kerstan A.; Trautmann A.; Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase. Clin Exp Allergy 2014,44(5),747-755","journal-title":"Clin Exp Allergy"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.jaip.2019.10.020","volume":"8","author":"Smith M.A.","year":"2020","unstructured":"Smith M.A.; Newton L.P.; Barcena Blanch M.A.; Cuervo-Pardo L.; Cho L.; Newton D.; Wang X.; Li M.; Lang D.M.; Risk for anaphylactic reaction from cardiac catheterization in patients receiving &#x3B2;-adrenergic blockers or angiotensin-converting enzyme-inhibitors. J Allergy Clin Immunol Pract 2020,8(6),1900-1905","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/emj.2005.023507","volume":"22","author":"Thomas M.","year":"2005","unstructured":"Thomas M.; Crawford I.; Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005,22(4),272-273","journal-title":"Emerg Med J"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","volume":"7","author":"Mueller U.R.","year":"2007","unstructured":"Mueller U.R.; Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007,7(4),337-341","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI25713","volume":"116","author":"Mackins C.J.","year":"2006","unstructured":"Mackins C.J.; Kano S.; Seyedi N.; Sch&#xE4;fer U.; Reid A.C.; Machida T.; Silver R.B.; Levi R.; Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia\/reperfusion. J Clin Invest 2006,116(4),1063-1070","journal-title":"J Clin Invest"},{"key":"ref=89","first-page":"638","volume":"4","author":"Lombardi A.","year":"2003","unstructured":"Lombardi A.; Vandelli R.; Cer&#xE8; E.; Di Pasquale G.; Silent acute myocardial infarction following a wasp sting. Ital Heart J 2003,4(9),638-641","journal-title":"Ital Heart J"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","volume":"120","author":"Simons F.","year":"2007","unstructured":"Simons F.; Frew A.; Ansotegui I.; Bochner B.; Golden D.; Finkelman F.; Leung D.; Lotvall J.; Marone G.; Metcalfe D.; M&#xFC;ller U.; Rosenwasser L.J.; Sampson H.A.; Schwartz L.B.; van Hage M.; Walls A.F.; Risk assessment in anaphylaxis: Current and future approaches. J Allergy Clin Immunol 2007,120(1),S2-S24","journal-title":"J Allergy Clin Immunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/01.CIR.97.10.971","volume":"97","author":"Patella V.","year":"1998","unstructured":"Patella V.; Marin&#xF2; I.; Arbustini E.; Lamparter-Schummert B.; Verga L.; Adt M.; Marone G.; Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998,97(10),971-978","journal-title":"Circulation"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/bja\/67.6.751","volume":"67","author":"Stellato C.","year":"1991","unstructured":"Stellato C.; Casolaro V.; Ciccarelli A.; Mastronardi P.; Mazzarella B.; Marone G.; General anaesthetics induce only histamine release selectively from human mast cells. Br J Anaesth 1991,67(6),751-758","journal-title":"Br J Anaesth"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/187152809787582462","volume":"8","author":"Ridella M.","year":"2009","unstructured":"Ridella M.; Bagdure S.; Nugent K.; Cevik C.; Kounis syndrome following beta-lactam antibiotic use: Review of literature. Inflamm Allergy Drug Targets 2009,8(1),11-16","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/ijerph18010333","volume":"18","author":"Poziomkowska-G\u0119sicka I.","year":"2021","unstructured":"Poziomkowska-G\u0119sicka I.; Kostrzewska M.; Kurek M.; Comorbidities and cofactors of anaphylaxis in patients with moderate to severe anaphylaxis. Analysis of data from the anaphylaxis Registry for West Pomerania Province, Poland. Int J Environ Res Public Health 2021,18(1),333","journal-title":"Int J Environ Res Public Health"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/cea.12369","volume":"44","author":"G&#xFC;len T.","year":"2014","unstructured":"G&#xFC;len T.; H&#xE4;gglund H.; Sander B.; Dahl&#xE9;n B.; Nilsson G.; The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy 2014,44(9),1179-1187","journal-title":"Clin Exp Allergy"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2005.08.007","volume":"110","author":"Kounis N.G.","year":"2006","unstructured":"Kounis N.G.; Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm? Int J Cardiol 2006,110(1),7-14","journal-title":"Int J Cardiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejim.2015.12.004","volume":"30","author":"Fassio F.","year":"2016","unstructured":"Fassio F.; Losappio L.; Antolin-Amerigo D.; Peveri S.; Pala G.; Preziosi D.; Massaro I.; Giuliani G.; Gasperini C.; Caminati M.; Heffler E.; Kounis syndrome: A concise review with focus on management. Eur J Intern Med 2016,30,7-10","journal-title":"Eur J Intern Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10286-017-0465-z","volume":"28","author":"Y-Hassan S.","year":"2018","unstructured":"Y-Hassan S.; Tornvall P.; Epidemiology, pathogenesis, and management of takotsubo syndrome. Clin Auton Res 2018,28(1),53-65","journal-title":"Clin Auton Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13601-019-0292-5","volume":"9","author":"Fehr D.","year":"2019","unstructured":"Fehr D.; Micaletto S.; Moehr T.; Schmid-Grendelmeier P.; Risk factors for severe systemic sting reactions in wasp (Vespula spp.) and honeybee (Apis mellifera) venom allergic patients. Clin Transl Allergy 2019,9(1),54","journal-title":"Clin Transl Allergy"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jaci.2010.02.009","volume":"125","author":"Gonz&#xE1;lez-P&#xE9;rez A.","year":"2010","unstructured":"Gonz&#xE1;lez-P&#xE9;rez A.; Aponte Z.; Vidaurre C.F.; Rodr&#xED;guez L.A.G.; Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review. J Allergy Clin Immunol 2010,125(5),1098-1104.e1","journal-title":"J Allergy Clin Immunol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaci.2006.12.622","volume":"119","author":"Bock S.A.","year":"2007","unstructured":"Bock S.A.; Mu&#xF1;oz-Furlong A.; Sampson H.A.; Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007,119(4),1016-1018","journal-title":"J Allergy Clin Immunol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/cea.12748","volume":"46","author":"Mullins R.J.","year":"2016","unstructured":"Mullins R.J.; Wainstein B.K.; Barnes E.H.; Liew W.K.; Campbell D.E.; Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy 2016,46(8),1099-1110","journal-title":"Clin Exp Allergy"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/ACI.0000000000000566","volume":"19","author":"Tanno L.K.","year":"2019","unstructured":"Tanno L.K.; Gonzalez-Estrada A.; Olivieri B.; Caminati M.; Asthma and anaphylaxis. Curr Opin Allergy Clin Immunol 2019,19(5),447-455","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11882-016-0598-5","volume":"16","author":"Lieberman P.","year":"2016","unstructured":"Lieberman P.; Garvey L.H.; Mast cells and anaphylaxis. Curr Allergy Asthma Rep 2016,16(3),20","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/ACI.0000000000000678","volume":"20","author":"O\u2019Connell M.P.","year":"2020","unstructured":"O\u2019Connell M.P.; Lyons J.J.; Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia. Curr Opin Allergy Clin Immunol 2020,20(5),431-437","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","volume":"140","author":"Akin C.","year":"2017","unstructured":"Akin C.; Mast cell activation syndromes. J Allergy Clin Immunol 2017,140(2),349-355","journal-title":"J Allergy Clin Immunol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"Valent P.","year":"2017","unstructured":"Valent P.; Akin C.; Metcalfe D.D.; Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 2017,129(11),1420-1427","journal-title":"Blood"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.iac.2016.08.017","volume":"37","author":"Schuch A.","year":"2017","unstructured":"Schuch A.; Brockow K.; Mastocytosis and anaphylaxis. Immunol Allergy Clin North Am 2017,37(1),153-164","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3389\/fimmu.2017.00792","volume":"8","author":"Gonz&#xE1;lez-de-Olano D.","year":"2017","unstructured":"Gonz&#xE1;lez-de-Olano D.; &#xC1;lvarez-Twose I.; Insights in anaphylaxis and clonal mast cell disorders. Front Immunol 2017,8,792","journal-title":"Front Immunol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","volume":"136","author":"Zanotti R.","year":"2015","unstructured":"Zanotti R.; Lombardo C.; Passalacqua G.; Caimmi C.; Bonifacio M.; De Matteis G.; Perbellini O.; Rossini M.; Schena D.; Busa M.; Marcotulli M.C.; Bil&#xF2; M.B.; Franchini M.; Marchi G.; Simioni L.; Bonadonna P.; Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels. J Allergy Clin Immunol 2015,136(1),135-139","journal-title":"J Allergy Clin Immunol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"070831211107005","DOI":"10.1111\/j.1365-2222.2007.02804.x","author":"Gonz&#xE1;lez de Olano D.","year":"2007","unstructured":"Gonz&#xE1;lez de Olano D.; de la Hoz Caballer B.; N&#xFA;&#xF1;ez L&#xF3;pez R.; S&#xE1;nchez Mu&#xF1;oz L.; Cuevas Agust&#xED;n M.; Di&#xE9;guez M.C.; &#xC1;lvarez Twose I.; Castells M.C.; Escribano Mora L.; Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007,070831211107005","journal-title":"Clin Exp Allergy"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","volume":"63","author":"Brockow K.","year":"2008","unstructured":"Brockow K.; Jofer C.; Behrendt H.; Ring J.; Anaphylaxis in patients with mastocytosis: A study on history, clinical features and risk factors in 120 patients. Allergy 2008,63(2),226-232","journal-title":"Allergy"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1398-9995.2009.02108.x","volume":"64","author":"Bonadonna P.","year":"2009","unstructured":"Bonadonna P.; Zanotti R.; Pagani M.; Caruso B.; Perbellini O.; Colarossi S.; Olivieri E.; Dama A.; Schiappoli M.; Senna G.; Antico A.; Passalacqua G.; How much specific is the association between hymenoptera venom allergy and mastocytosis? Allergy 2009,64(9),1379-1382","journal-title":"Allergy"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cea.12225","volume":"44","author":"G&#xFC;len T.","year":"2014","unstructured":"G&#xFC;len T.; H&#xE4;gglund H.; Dahl&#xE9;n B.; Nilsson G.; High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Clin Exp Allergy 2014,44(1),121-129","journal-title":"Clin Exp Allergy"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","volume":"137","author":"Hartmann K.","year":"2016","unstructured":"Hartmann K.; Escribano L.; Grattan C.; Brockow K.; Carter M.C.; Alvarez-Twose I.; Matito A.; Broesby-Olsen S.; Siebenhaar F.; Lange M.; Niedoszytko M.; Castells M.; Oude Elberink J.N.G.; Bonadonna P.; Zanotti R.; Hornick J.L.; Torrelo A.; Grabbe J.; Rabenhorst A.; Nedoszytko B.; Butterfield J.H.; Gotlib J.; Reiter A.; Radia D.; Hermine O.; Sotlar K.; George T.I.; Kristensen T.K.; Kluin-Nelemans H.C.; Yavuz S.; H&#xE4;gglund H.; Sperr W.R.; Schwartz L.B.; Triggiani M.; Maurer M.; Nilsson G.; Horny H.P.; Arock M.; Orfao A.; Metcalfe D.D.; Akin C.; Valent P.; Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma and Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 2016,137(1),35-45","journal-title":"J Allergy Clin Immunol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11882-021-01010-1","volume":"21","author":"Wu R.","year":"2021","unstructured":"Wu R.; Lyons J.J.; Hereditary alpha-tryptasemia: A commonly inherited modifier of anaphylaxis. Curr Allergy Asthma Rep 2021,21(5),33","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000497235","volume":"179","author":"Aniceto V.","year":"2019","unstructured":"Aniceto V.; Dias M.M.; Melo J.M.L.; Trevisan-Neto O.; Aragon D.C.; Maia L.S.M.; Moreno A.S.; Arruda L.K.; Serum baseline tryptase level as a marker for the severity of anaphylaxis. Int Arch Allergy Immunol 2019,179(3),201-208","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1398-9995.2009.02302.x","volume":"65","author":"Guenova E.","year":"2010","unstructured":"Guenova E.; Volz T.; Eichner M.; Hoetzenecker W.; Caroli U.; Griesinger G.; Burow G.; Mitev V.; Biedermann T.; Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Allergy 2010,65(7),919-923","journal-title":"Allergy"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","volume":"10","author":"Bonadonna P.","year":"2010","unstructured":"Bonadonna P.; Zanotti R.; M&#xFC;ller U.; Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol 2010,10(4),347-353","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","volume":"125","author":"&#xC1;lvarez-Twose I.","year":"2010","unstructured":"&#xC1;lvarez-Twose I.; Gonz&#xE1;lez de Olano D.; S&#xE1;nchez-Mu&#xF1;oz L.; Matito A.; Esteban-L&#xF3;pez M.I.; Vega A.; Mateo M.B.; Alonso D&#xED;az de Durana M.D.; de la Hoz B.; del Pozo Gil M.D.; Caballero T.; Rosado A.; S&#xE1;nchez Matas I.; Teod&#xF3;sio C.; Jara-Acevedo M.; Mollejo M.; Garc&#xED;a-Montero A.; Orfao A.; Escribano L.; Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 2010,125(6),1269-1278.e2","journal-title":"J Allergy Clin Immunol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","volume":"124","author":"Ru&#xEB;ff F.","year":"2009","unstructured":"Ru&#xEB;ff F.; Przybilla B.; Bil&#xF3; M.B.; M&#xFC;ller U.; Scheipl F.; Aberer W.; Birnbaum J.; Bodzenta-Lukaszyk A.; Bonifazi F.; Bucher C.; Campi P.; Darsow U.; Egger C.; Haeberli G.; Hawranek T.; K&#xF6;rner M.; Kucharewicz I.; K&#xFC;chenhoff H.; Lang R.; Quercia O.; Reider N.; Severino M.; Sticherling M.; Sturm G.J.; W&#xFC;thrich B.; Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009,124(5),1047-1054","journal-title":"J Allergy Clin Immunol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","volume":"42","author":"Fellinger C.","year":"2014","unstructured":"Fellinger C.; Hemmer W.; W&#xF6;hrl S.; Sesztak-Greinecker G.; Jarisch R.; Wantke F.; Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol 2014,42(6),544-552","journal-title":"Allergol Immunopathol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","volume":"33","author":"Haeberli G.","year":"2003","unstructured":"Haeberli G.; Br&#xF6;nnimann M.; Hunziker T.; M&#xFC;ller U.; Elevated basal serum tryptase and hymenoptera venom allergy: Relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003,33(9),1216-1220","journal-title":"Clin Exp Allergy"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/all.12617","volume":"70","author":"Bonadonna P.","year":"2015","unstructured":"Bonadonna P.; Pagani M.; Aberer W.; Bil&#xF2; M.B.; Brockow K.; Oude Elberink H.; Garvey L.; Mosbech H.; Romano A.; Zanotti R.; Torres M.J.; Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper. Allergy 2015,70(7),755-763","journal-title":"Allergy"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1710-1492-10-19","volume":"10","author":"Seitz C.S.","year":"2014","unstructured":"Seitz C.S.; Brockow K.; Hain J.; Trautmann A.; Non-steroidal anti-inflammatory drug hypersensitivity: Association with elevated basal serum tryptase? Allergy Asthma Clin Immunol 2014,10(1),19","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","volume":"141","author":"Carter M.C.","year":"2018","unstructured":"Carter M.C.; Desai A.; Komarow H.D.; Bai Y.; Clayton S.T.; Clark A.S.; Ruiz-Esteves K.N.; Long L.M.; Cantave D.; Wilson T.M.; Scott L.M.; Simakova O.; Jung M.Y.; Hahn J.; Maric I.; Metcalfe D.D.; A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 2018,141(1),180-188.e3","journal-title":"J Allergy Clin Immunol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ajd.12146","volume":"56","author":"Aberer E.","year":"2015","unstructured":"Aberer E.; Savic S.; Bretterklieber A.; Reiter H.; Berghold A.; Aberer W.; Disease spectrum in patients with elevated serum tryptase levels. Australas J Dermatol 2015,56(1),7-13","journal-title":"Australas J Dermatol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"Akin C.","year":"2007","unstructured":"Akin C.; Scott L.M.; Kocabas C.N.; Kushnir-Sukhov N.; Brittain E.; Noel P.; Metcalfe D.D.; Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with &#x201C;idiopathic&#x201D; anaphylaxis. Blood 2007,110(7),2331-2333","journal-title":"Blood"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11882-021-00988-y","volume":"21","author":"Gulen T.","year":"2021","unstructured":"Gulen T.; Akin C.; Idiopathic anaphylaxis: A perplexing diagnostic challenge for allergists. Curr Allergy Asthma Rep 2021,21(2),11","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=130","first-page":"370","volume":"73","author":"Khan D.A.","year":"1994","unstructured":"Khan D.A.; Yocum M.W.; Clinical course of idiopathic anaphylaxis. Ann Allergy 1994,73(4),370-374","journal-title":"Ann Allergy"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/ACI.0000000000000377","volume":"17","author":"G&#xFC;len T.","year":"2017","unstructured":"G&#xFC;len T.; Akin C.; Pharmacotherapy of mast cell disorders. Curr Opin Allergy Clin Immunol 2017,17(4),295-303","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7326\/0003-4819-114-2-133","volume":"114","author":"Wong S.","year":"1991","unstructured":"Wong S.; Yarnold P.R.; Yango C.; Patterson R.; Harris K.E.; Outcome of prophylactic therapy for idiopathic anaphylaxis. Ann Intern Med 1991,114(2),133-136","journal-title":"Ann Intern Med"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1081-1206(10)60091-9","volume":"102","author":"Warrier P.","year":"2009","unstructured":"Warrier P.; Casale T.B.; Omalizumab in idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2009,102(3),257-258","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S1081-1206(10)60296-7","volume":"101","author":"Jones J.D.","year":"2008","unstructured":"Jones J.D.; Marney S.R.; Fahrenholz J.M.; Idiopathic anaphylaxis successfully treated with omalizumab. Ann Allergy Asthma Immunol 2008,101(5),550-551","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21911\/aai.647","volume":"20","author":"&#xD6;ztop N.","year":"2022","unstructured":"&#xD6;ztop N.; Demir ; beyaz &#x15E;.; T&#xFC;zer &#xD6;.C.; &#xC7;olako&#x11F;lu B.; B&#xFC;y&#xFC;k&#xF6;zt&#xFC;rk S.; Gelincik A.; Omalizumab in practice: Ten-year experience of a tertiary referral allergy centre. Asthma Allergy Immunology 2022,20(1),36-47","journal-title":"Asthma Allergy Immunology"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.2020006157","volume":"137","author":"Greiner G.","year":"2021","unstructured":"Greiner G.; Sprinzl B.; G&#xF3;rska A.; Ratzinger F.; Gurbisz M.; Witzeneder N.; Schmetterer K.G.; Gisslinger B.; Uyanik G.; Hadzijusufovic E.; Esterbauer H.; Gleixner K.V.; Krauth M.T.; Pfeilst&#xF6;cker M.; Keil F.; Gisslinger H.; Nedoszytko B.; Niedoszytko M.; Sperr W.R.; Valent P.; Hoermann G.; Hereditary &#x3B1; tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Blood 2021,137(2),238-247","journal-title":"Blood"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jaip.2017.11.025","volume":"6","author":"Bonadonna P.","year":"2018","unstructured":"Bonadonna P.; Zanotti R.; Pagani M.; Bonifacio M.; Scaffidi L.; Olivieri E.; Franchini M.; Reccardini F.; Costantino M.T.; Roncallo C.; Mauro M.; Boni E.; Rizzini F.L.; Bil&#xF2; M.B.; Marcarelli A.R.; Passalacqua G.; Anaphylactic reactions after discontinuation of hymenoptera venom immunotherapy: A clonal mast cell disorder should be suspected. J Allergy Clin Immunol Pract 2018,6(4),1368-1372","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=138","author":"Manian D.V.","year":"2021","unstructured":"Manian D.V.; Volcheck G.W.; Perioperative anaphylaxis: Evaluation and management. Clin Rev Allergy Immunol 2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bja.2018.04.001","volume":"121","author":"Cook T.M.","year":"2018","unstructured":"Cook T.M.; Harper N.J.N.; Farmer L.; Garcez T.; Floss K.; Marinho S.; Torevell H.; Warner A.; McGuire N.; Ferguson K.; Hitchman J.; Egner W.; Kemp H.; Thomas M.; Lucas D.N.; Nasser S.; Karanam S.; Kong K.L.; Farooque S.; Bellamy M.; McGlennan A.; Moonesinghe S.R.; Anaesthesia, surgery, and life-threatening allergic reactions: Protocol and methods of the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists. Br J Anaesth 2018,121(1),124-133","journal-title":"Br J Anaesth"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bja.2021.06.036","volume":"127","author":"Gonzalez-Estrada A.","year":"2021","unstructured":"Gonzalez-Estrada A.; Campbell R.L.; Carrillo-Martin I.; Renew J.R.; Rank M.A.; Volcheck G.W.; Incidence and risk factors for near-fatal and fatal outcomes after perioperative and periprocedural anaphylaxis in the USA, 2005\u20132014. Br J Anaesth 2021,127(6),890-896","journal-title":"Br J Anaesth"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.jaip.2019.05.033","volume":"7","author":"Volcheck G.W.","year":"2019","unstructured":"Volcheck G.W.; Hepner D.L.; Identification and management of perioperative anaphylaxis. J Allergy Clin Immunol Pract 2019,7(7),2134-2142","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.bja.2019.01.027","volume":"123","author":"Mertes P.M.","year":"2019","unstructured":"Mertes P.M.; Ebo D.G.; Garcez T.; Rose M.; Sabato V.; Takazawa T.; Cooke P.J.; Clarke R.C.; Dewachter P.; Garvey L.H.; Guttormsen A.B.; Hepner D.L.; Hopkins P.M.; Khan D.A.; Kolawole H.; Kopac P.; Kr&#xF8;igaard M.; Laguna J.J.; Marshall S.D.; Platt P.R.; Sadleir P.H.M.; Savic L.C.; Savic S.; Volcheck G.W.; Voltolini S.; Comparative epidemiology of suspected perioperative hypersensitivity reactions. Br J Anaesth 2019,123(1),e16-e28","journal-title":"Br J Anaesth"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s11096-019-00902-7","volume":"41","author":"Huang W.","year":"2019","unstructured":"Huang W.; Li X.; Xiang Y.; Li J.; Zhou X.; Zheng X.; Cheng B.; Zhu S.; Risk factors and prevention for perioperative anaphylaxis: A nested case-control study. Int J Clin Pharm 2019,41(6),1442-1450","journal-title":"Int J Clin Pharm"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","volume":"121","author":"Harper N.J.N.","year":"2018","unstructured":"Harper N.J.N.; Cook T.M.; Garcez T.; Farmer L.; Floss K.; Marinho S.; Torevell H.; Warner A.; Ferguson K.; Hitchman J.; Egner W.; Kemp H.; Thomas M.; Lucas D.N.; Nasser S.; Karanam S.; Kong K.L.; Farooque S.; Bellamy M.; McGuire N.; Anaesthesia, surgery, and life-threatening allergic reactions: Epidemiology and clinical features of perioperative anaphylaxis in the 6 National Audit Project (NAP6). Br J Anaesth 2018,121(1),159-171","journal-title":"Br J Anaesth"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000436969","volume":"167","author":"Matito A.","year":"2015","unstructured":"Matito A.; Morgado J.M.; S&#xE1;nchez-L&#xF3;pez P.; &#xC1;lvarez-Twose I.; S&#xE1;nchez-Mu&#xF1;oz L.; Orfao A.; Escribano L.; Management of anesthesia in adult and pediatric mastocytosis: A study of the spanish network on mastocytosis (REMA) based on 726 anesthetic procedures. Int Arch Allergy Immunol 2015,167(1),47-56","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.lpm.2016.02.024","volume":"45","author":"Mertes P.M.","year":"2016","unstructured":"Mertes P.M.; Volcheck G.W.; Garvey L.H.; Takazawa T.; Platt P.R.; Guttormsen A.B.; Tacquard C.; Epidemiology of perioperative anaphylaxis. Presse Med 2016,45(9),758-767","journal-title":"Presse Med"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jaip.2017.03.016","volume":"5","author":"Hsu Blatman K.S.","year":"2017","unstructured":"Hsu Blatman K.S.; Hepner D.L.; Current knowledge and management of hypersensitivity to perioperative drugs and radiocontrast media. J Allergy Clin Immunol Pract 2017,5(3),587-592","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/ACO.0000000000000857","volume":"33","author":"Savic L.C.","year":"2020","unstructured":"Savic L.C.; Garvey L.H.; Perioperative anaphylaxis: Diagnostic challenges and management. Curr Opin Anaesthesiol 2020,33(3),448-453","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/pds.1196","volume":"15","author":"Light K.P.","year":"2006","unstructured":"Light K.P.; Lovell A.T.; Butt H.; Fauvel N.J.; Holdcroft A.; Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: Are there differences between males and females? Pharmacoepidemiol Drug Saf 2006,15(3),151-160","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/ACO.0b013e3283466c13","volume":"24","author":"Dewachter P.","year":"2011","unstructured":"Dewachter P.; Mouton-Faivre C.; Castells M.C.; Hepner D.L.; Anesthesia in the patient with multiple drug allergies: Are all allergies the same? Curr Opin Anaesthesiol 2011,24(3),320-325","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1398-9995.2010.02518.x","volume":"66","author":"Florvaag E.","year":"2011","unstructured":"Florvaag E.; Johansson S.G.O.; Irgens &#xC5;.; de Pater G.H.; IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011,66(7),955-960","journal-title":"Allergy"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/bja\/aes506","volume":"110","author":"Sadleir P.H.M.","year":"2013","unstructured":"Sadleir P.H.M.; Clarke R.C.; Bunning D.L.; Platt P.R.; Anaphylaxis to neuromuscular blocking drugs: Incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 2013,110(6),981-987","journal-title":"Br J Anaesth"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.bja.2018.03.004","volume":"120","author":"Chiriac A.M.","year":"2018","unstructured":"Chiriac A.M.; Tacquard C.; Fadhel N.B.; Pellerin C.; Malinovsky J.M.; Mertes P.M.; Demoly P.; Safety of subsequent general anaesthesia in patients allergic to neuromuscular blocking agents: Value of allergy skin testing. Br J Anaesth 2018,120(6),1437-1440","journal-title":"Br J Anaesth"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1111\/all.13820","volume":"74","author":"Garvey L.H.","year":"2019","unstructured":"Garvey L.H.; Ebo D.G.; Mertes P.M.; Dewachter P.; Garcez T.; Kopac P.; Laguna J.J.; Chiriac A.M.; Terreehorst I.; Voltolini S.; Scherer K.; An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions. Allergy 2019,74(10),1872-1884","journal-title":"Allergy"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1034\/j.1399-6576.2001.451020.x","volume":"45","author":"Garvey L.H.","year":"2001","unstructured":"Garvey L.H.; Roed-Petersen J.; Husum B.; Anaphylactic reactions in anaesthetised patients - four cases of chlorhexidine allergy. Acta Anaesthesiol Scand 2001,45(10),1290-1294","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/all.12466","volume":"69","author":"Opstrup M.S.","year":"2014","unstructured":"Opstrup M.S.; Malling H.J.; Kr&#xF8;igaard M.; Mosbech H.; Skov P.S.; Poulsen L.K.; Garvey L.H.; Standardized testing with chlorhexidine in perioperative allergy - a large single-centre evaluation. Allergy 2014,69(10),1390-1396","journal-title":"Allergy"},{"key":"ref=157","first-page":"353","volume":"20","author":"Caballero M.R.","year":"2010","unstructured":"Caballero M.R.; Lukawska J.; Dugu&#xE9; P.; A hidden cause of perioperative anaphylaxis. J Investig Allergol Clin Immunol 2010,20(4),353-354","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.anai.2017.09.002","volume":"119","author":"Caraballo J.","year":"2017","unstructured":"Caraballo J.; Binkley E.; Han I.; Dowden A.; Intraoperative anaphylaxis to bacitracin during scleral buckle surgery. Ann Allergy Asthma Immunol 2017,119(6),559-560","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fct.2012.10.027","volume":"52","author":"Lucov&#xE1; M.","year":"2013","unstructured":"Lucov&#xE1; M.; Hojerov&#xE1; J.; Pa&#x17E;ourekov&#xE1; S.; Klimov&#xE1; Z.; Absorption of triphenylmethane dyes brilliant blue and patent blue through intact skin, shaven skin and lingual mucosa from daily life products. Food Chem Toxicol 2013,52,19-27","journal-title":"Food Chem Toxicol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jaci.2008.04.040","volume":"122","author":"Mertes P.M.","year":"2008","unstructured":"Mertes P.M.; Malinovsky J.M.; Mouton-Faivre C.; Bonnet-Boyer M.C.; Benhaijoub A.; Lavaud F.; Valfrey J.; O\u2019Brien J.; Pirat P.; Lalourcey L.; Demoly P.; Anaphylaxis to dyes during the perioperative period: Reports of 14 clinical cases. J Allergy Clin Immunol 2008,122(2),348-352","journal-title":"J Allergy Clin Immunol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1398-9995.2009.02192.x","volume":"65","author":"Hunting A.S.","year":"2010","unstructured":"Hunting A.S.; Nopp A.; Johansson S.G.O.; Andersen F.; Wilhelmsen V.; Guttormsen A.B.; Anaphylaxis to patent blue V.I. Clinical aspects. Allergy 2010,65(1),117-123","journal-title":"Allergy"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/cea.12418","volume":"45","author":"Tejedor Alonso M.A.","year":"2015","unstructured":"Tejedor Alonso M.A.; Moro Moro M.; M&#xFA;gica Garc&#xED;a M.V.; Epidemiology of anaphylaxis. Clin Exp Allergy 2015,45(6),1027-1039","journal-title":"Clin Exp Allergy"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.jaip.2020.11.025","volume":"9","author":"Banerji A.","year":"2021","unstructured":"Banerji A.; Bhattacharya G.; Huebner E.; Fu X.; Camargo C.A.; Guyer A.; Kuhlen J.L.; Blumenthal K.G.; Perioperative allergic reactions: Allergy assessment and subsequent anesthesia. J Allergy Clin Immunol Pract 2021,9(5),1980-1991","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1399-6576.2007.01313.x","volume":"51","author":"Kroigaard M.","year":"2007","unstructured":"Kroigaard M.; Garvey L.H.; Gillberg L.; Johansson S.G.O.; Mosbech H.; Florvaag E.; Harboe T.; Eriksson L.I.; Dahlgren G.; Seeman-Lodding H.; Takala R.; Wattwil M.; Hirlekar G.; Dahl&#xE9;n B.; Guttormsen A.B.; Scandinavian clinical practice guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007,51(6),655-670","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.bja.2019.04.044","volume":"123","author":"Garvey L.H.","year":"2019","unstructured":"Garvey L.H.; Dewachter P.; Hepner D.L.; Mertes P.M.; Voltolini S.; Clarke R.; Cooke P.; Garcez T.; Guttormsen A.B.; Ebo D.G.; Hopkins P.M.; Khan D.A.; Kopac P.; Kr&#xF8;igaard M.; Laguna J.J.; Marshall S.; Platt P.; Rose M.; Sabato V.; Sadleir P.; Savic L.; Savic S.; Scherer K.; Takazawa T.; Volcheck G.W.; Kolawole H.; Management of suspected immediate perioperative allergic reactions: An international overview and consensus recommendations. Br J Anaesth 2019,123(1),e50-e64","journal-title":"Br J Anaesth"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s40629-018-0071-1","volume":"27","author":"Pf&#xFC;tzner W.","year":"2018","unstructured":"Pf&#xFC;tzner W.; Brockow K.; Perioperative drug reactions - practical recommendations for allergy testing and patient management. Allergo J Int 2018,27(4),126-129","journal-title":"Allergo J Int"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000321954","volume":"156","author":"Matito  A.","year":"2011","unstructured":"Matito A.; Alvarez-Twose I.; Morgado JM; Sanchez-Munoz L; Orfao A; Escribano L; Clinical impact of pregnancy in mastocytosis: A study of the spanish network on mastocytosis (REMA) in 45 cases  Int Arch Allergy Immunol 2011,156(1),104-111","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221207105214","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211678\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221207105214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:18:39Z","timestamp":1679977119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211678\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":167,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666221207105214","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}